Xenon Pharmaceuticals Inc. (XENE): Shares Outstanding
80.01M
As of 2025-12-31
96.75M
As of 2026-06-30
+8.5%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 80.01M | +4.7% | 2026-02-26, Balance as of period end |
| 2024-12-31 | 76.42M | +1.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | 75.37M | +20.4% | 2025-02-27, Balance as of period end |
| 2022-12-31 | 62.59M | +21.2% | 2024-02-29, Balance as of period end |
| 2021-12-31 | 51.63M | n/c | 2023-03-01, Balance as of period end |
| 2020-12-31 | 35.01M | +24.4% | 2022-03-01, Balance as of period end |
| 2019-12-31 | 28.14M | +9.3% | 2021-03-01, Balance as of period end |
| 2018-12-31 | 25.75M | n/c | 2020-03-09, Balance as of period end |
| 2017-12-31 | 18.00M | +0.4% | 2019-03-06, Balance as of period end |
| 2016-12-31 | 17.93M | +24.6% | 2018-03-07, Balance as of period end |
| 2015-12-31 | 14.39M | +1.4% | 2017-03-08, Balance as of period end |
| 2014-12-31 | 14.18M | +954.7% | 2016-03-08, Balance as of period end |
| 2013-12-31 | 1.34M | n/a | 2015-03-12, Balance as of period end |